PureCol and Type III Hydrogels for HIV Study

PureCol and Type III Hydrogels for HIV Study

11/30/23

Publication Title:

An Environmental Restriction Impairs HIV-I Virion Fusion and Triggers Innate Immune Recognition

 

Advanced BioMatrix Products Used: 

PureCol® Type I Collagen, Atelocollagen, 3 mg/ml

Collagen Type III

Collagen eBrochure

 

How the products were used:

Concentrated HIV virus was added to PureCol and Collagen type III hydrogels to study the impact of tissue-like environments on viral spread. 

 

 

Article Conclusion:

 These results suggest that ERVI represents a broadly acting, tissue-intrinsic barrier to virus spread that reduces the fusogenicity of cell-free virions and sensitizes them for innate immune recognition.

 

Link to the publication:

https://www.biorxiv.org/content/10.1101/2023.11.22.568261v1.full 

 


Share Article: